FundedIQ
Biotechnology

Fluent: Funding, Investors & Team (Sep 2026)

The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication for persons with neurological disorders and eventually revolutionizing human-AI interaction for everyone.

fluentbci.com LinkedIn Melbourne, Australia 1-10 employees
Biotechnology Human Computer Interaction B2C
Total raised
$2.0M
Rounds
1
Latest
Seed
Jun 2026

Fluent has raised $2.0M across 1 funding round on record, the most recent a Seed of $2.0M announced in Jun 2026.

That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Fluent Company Profile and Key Stats

Total funding raised
$2.0M
across 1 round on record
Funding rounds on record
1
Latest funding round
Seed
$2.0M in Jun 2026
Employees
1-10
reported band
Headquarters
Melbourne, Australia

Latest funding round on record: Jun 2026.

Fluent Funding Rounds

Date
Round
Amount
Seed
$2.0M

Fluent Founders and Leadership Team

Name
Role
Contact
David E
Founder

No contact details are on record for this team yet.

Fluent Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
1,156
$4.0M
16,485
$3.1M

Fluent's latest round of $2.0M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Fluent in Biotechnology and Melbourne

Companies Similar to Fluent

AdvanCell is a company that focuses on developing innovative cancer treatments using alpha-emitting isotopes…

Series D $315M

Mesoblast is a developer of biologic products for the broad field of regenerative medicine. Mesoblast's…

Undisclosed round $50.0M

Microba Life Sciences Ltd. provides consumers, doctors, and researchers with gut microbiome testing services…

Undisclosed round $3.5M

Algenie was founded on a simple realization: algae has the potential to save the earth, but only if it is…

Undisclosed round $990k

Paradigm Pharmaceuticals is a global biopharmaceutical company driven to discover, develop, and deliver…

Undisclosed round $10.1M

Imugene is a publicly-listed biotechnology company with operations in America and Europe,

Undisclosed round $8.6M

BiomeBank’s mission is to treat and prevent disease by restoring gut microbial ecology

Undisclosed round $10.8M

Telix Pharmaceuticals Ltd is a clinical-stage biotechnology company engaged in developing and commercializing…

Undisclosed round $600M

Cauldron Ferm is a technique that speeds up the production of precision fermented prototypes to commercial…

Series A $13.3M

HydGene Renewables is developing a biotechnology platform that produces on-site green hydrogen from waste…

Undisclosed round $1.4M

Swan Genomics is focused on commercialising an innovative new approach to DNA sequencing to deliver more…

Undisclosed round $320k

OncoRes Medical develops an imaging technology to provide intraoperative information available to surgeons to…

Undisclosed round $19.2M

Fluent Funding FAQs

What does Fluent do?

The objective of Fluent is to seamlessly integrate humans with AI, improving interaction and communication for persons with neurological disorders and eventually revolutionizing human-AI interaction for everyone.

How much funding has Fluent raised?

Fluent has raised $2.0M across 1 round on record. The most recent is a Seed of $2.0M announced in Jun 2026.

When did Fluent last raise funding?

Fluent's most recent funding round on record is a Seed of $2.0M, announced in Jun 2026.

Who founded Fluent?

FundedIQ lists David E (Founder) at Fluent.

Where is Fluent headquartered?

Fluent is based in Melbourne, Victoria, Australia.

How many employees does Fluent have?

Fluent is in the 1-10 employee band.

How does Fluent's funding compare to other Biotechnology startups?

Fluent's latest round of $2.0M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Fluent Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Fluent is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.